A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28090403)

Published in Curr Emerg Hosp Med Rep on July 06, 2016

Authors

Bory Kea1, Tahroma Alligood2, Vincent Manning3, Merritt Raitt4

Author Affiliations

1: Assistant Professor, Department of Emergency Medicine, Oregon Health & Science University School of Medicine, Mailcode CR114, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, 503-494-4430 (p), 503-494-8237 (f).
2: Research Associate, Department of Emergency Medicine, Oregon Health & Science University School of Medicine, Doctoral Student, Department of Public Health & Preventive Medicine, OHSU/PSU School of Public Health, Mailcode CR114, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, 503-494-4566.
3: Medical Student (4 Year), Oregon Health & Science University School of Medicine, 4460 SW Scholls Ferry Road, Apt. #3, Portland, OR 97225.
4: Professor of Medicine, Oregon Health and Science University, Director Electrophysiology Service, VA Health Center System, 3710 SW US Veterans Hospital Rd, Portland, OR 97239, 503-220-8262.

Articles cited by this

Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest (2009) 14.06

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96

Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2013) 7.70

Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA (2011) 4.73

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60

Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation. JAMA (2014) 4.21

Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med (2014) 3.63

Stroke prevention in atrial fibrillation: a systematic review. JAMA (2015) 3.28

Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87

Atrial fibrillation and death after myocardial infarction: a community study. Circulation (2011) 2.63

Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation (2011) 2.63

Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation (2013) 2.48

Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc (2013) 2.47

Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation (2015) 2.33

Abnormal troponin level as short-term predictor of poor outcome in acute atrial fibrillation. Am J Emerg Med (2013) 2.02

Irbesartan in patients with atrial fibrillation. N Engl J Med (2011) 1.84

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J (2014) 1.81

Role of the CHADS2 score in acute coronary syndromes: risk of subsequent death or stroke in patients with and without atrial fibrillation. Chest (2011) 1.72

Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol (2013) 1.61

Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study. Europace (2011) 1.61

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial. Eur Heart J (2013) 1.53

Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study. Chest (2011) 1.51

New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry). Am J Cardiol (2013) 1.43

Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial. Europace (2013) 1.42

Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients? Am J Med (2010) 1.24

Third universal definition of myocardial infarction. Glob Heart (2012) 1.14

Long-term trends in short-term outcomes in acute myocardial infarction. Am J Med (2011) 0.99

Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. Eur Heart J (2013) 0.97

Atrial fibrillation and incident myocardial infarction in the elderly. Clin Cardiol (2014) 0.95

Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation. Eur Heart J (2011) 0.94

Blood count in new onset atrial fibrillation after acute myocardial infarction - a hypothesis generating study. Indian J Med Res (2014) 0.94

Patient with atrial fibrillation and myocardial infarction due to coronary artery embolism treated with thrombus aspiration. Kardiol Pol (2013) 0.92

Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. Heart Rhythm (2014) 0.91

Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart Rhythm (2011) 0.91

Restrictive left ventricular filling pattern and risk of new-onset atrial fibrillation after acute myocardial infarction. Am J Cardiol (2011) 0.91

Cardioembolic acute myocardial infarction and stroke in a patient with persistent atrial fibrillation. Int J Cardiol (2012) 0.88

Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. Curr Cardiol Rep (2012) 0.87

Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Am J Cardiol (2013) 0.87

The prognostic value of atrial fibrillation on 30-day clinical outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int Heart J (2011) 0.86

An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes. J Am Heart Assoc (2013) 0.86

Can we predict outcomes in atrial fibrillation? Clin Cardiol (2012) 0.85

Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort study. PLoS One (2012) 0.84

Outcomes associated with comorbid atrial fibrillation and heart failure in Medicare beneficiaries with acute coronary syndrome. BMC Health Serv Res (2014) 0.83

Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study. Thromb Haemost (2014) 0.83

Effect of type of atrial fibrillation on prognosis in acute myocardial infarction treated invasively. Am J Cardiol (2012) 0.83

Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients. Mayo Clin Proc (2014) 0.82

Unrecognized myocardial infarction and risk of atrial fibrillation: the Rotterdam Study. Int J Cardiol (2013) 0.82

B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Peptides (2012) 0.82

Temporal trends in the occurrence and outcomes of atrial fibrillation in patients with acute myocardial infarction (from the Atherosclerosis Risk in Communities Surveillance Study). Am J Cardiol (2014) 0.82

Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both. Vasc Health Risk Manag (2014) 0.81

Activated inflammation is related to the incidence of atrial fibrillation in patients with acute myocardial infarction. Intern Med (2012) 0.81

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation. Int J Clin Pharm (2014) 0.81

Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry. Int J Cardiol (2013) 0.81

Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation. Eur J Clin Invest (2013) 0.80

Vitamin D deficiency is unrelated to type of atrial fibrillation and its complications. Dan Med J (2012) 0.80

Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation. Int J Cardiol (2012) 0.80

Usefulness of heart rate to predict one-year mortality in patients with atrial fibrillation and acute myocardial infarction (from the OMEGA trial). Am J Cardiol (2012) 0.79

Clinical utility and prognostic significance of measuring troponin I levels in patients presenting to the emergency room with atrial fibrillation. Clin Cardiol (2014) 0.79

Statins therapy can reduce the risk of atrial fibrillation in patients with acute coronary syndrome: a meta-analysis. Int J Med Sci (2013) 0.79

Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome. Am J Med (2012) 0.79

Effect of new versus known versus no atrial fibrillation on 30-day and 10-year mortality in patients with acute coronary syndrome. Am J Cardiol (2012) 0.79

Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. Europace (2014) 0.79

Relation of inflammation and left atrial remodeling in atrial fibrillation occurring in early phase of acute myocardial infarction. Int J Cardiol (2009) 0.79

Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation. Can J Cardiol (2012) 0.79

New-onset versus chronic atrial fibrillation in acute myocardial infarction: differences in short- and long-term follow-up. Clin Res Cardiol (2010) 0.78

Prognostic significance of prevalent and incident atrial fibrillation among patients hospitalized with acute coronary syndrome: findings from the Gulf RACE-2 Registry. Angiology (2011) 0.78

Obesity and new-onset atrial fibrillation in acute myocardial infarction: a gender specific risk factor. Int J Cardiol (2014) 0.78

Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease. Europace (2012) 0.78

Plasma N-terminal pro-brain natriuretic peptide levels predict new-onset atrial fibrillation in patients with acute myocardial infarction. Int J Cardiol (2013) 0.78

New-onset atrial fibrillation predicts malignant arrhythmias in post-myocardial infarction patients--a Cardiac Arrhythmias and RIsk Stratification after acute Myocardial infarction (CARISMA) substudy. Am Heart J (2013) 0.78

How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation. Ann Hematol (2015) 0.77

Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study. Eur J Prev Cardiol (2012) 0.77

Association between CHADS2 score and the preventive effect of statin therapy on new-onset atrial fibrillation in patients with acute myocardial infarction. PLoS One (2013) 0.77

Myocardial infarction and atrial fibrillation: different impact of anti-IIa vs anti-Xa new oral anticoagulants: a meta-analysis of the interventional trials. Int J Cardiol (2014) 0.77

New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study. J Am Heart Assoc (2014) 0.77

Prognosis of different types of atrial fibrillation in the primary angioplasty era. Coron Artery Dis (2012) 0.76

Functional mitral regurgitation after a first non-ST segment elevation acute coronary syndrome: very-long-term follow-up, prognosis and contribution to left ventricular enlargement and atrial fibrillation development. Heart (2013) 0.76

Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study). Am J Cardiol (2013) 0.76

Multiple cardiovascular complications in a patient with missed small apical myocardial infarction caused by a coronary artery thrombus of uncertain origin. Kardiol Pol (2013) 0.76

Prognostic impact of atrial fibrillation in acute coronary syndromes: results from the ARIAM registry. Eur Heart J Acute Cardiovasc Care (2013) 0.76

Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation: the clinical dilemma of triple therapy. Curr Opin Cardiol (2014) 0.76

Clinical significance of chronic kidney disease and atrial fibrillation on morbidity and mortality in patients with acute myocardial infarction. Am J Nephrol (2014) 0.76

Risk of cardiac arrhythmias and conduction abnormalities in patients with acute myocardial infarction receiving packed red blood cell transfusions. J Crit Care (2010) 0.76

Relation of contrast induced nephropathy to new onset atrial fibrillation in acute coronary syndrome. Am J Cardiol (2014) 0.76

Prognosis of silent atrial fibrillation after acute myocardial infarction at 1-year follow-up. Heart (2015) 0.76

An uncommon cause of myocardial infarction. Heart Lung Circ (2011) 0.76

Predictors of outcome in stable outpatients with peripheral artery disease. Intern Emerg Med (2012) 0.75

Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study. BMC Cardiovasc Disord (2011) 0.75

Coronary thrombus in ST elevation myocardial infarction and atrial fibrillation. J Thromb Thrombolysis (2013) 0.75

Acute myocardial infarction due to coronary artery embolus associated with atrial fibrillation. Acute Card Care (2013) 0.75

Atrial fibrillation in Middle Eastern Arab and South Asian patients hospitalized with acute myocardial infarction: experience from a 20-year registry in qatar (1991-2010). Acta Cardiol (2013) 0.75

Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions. Circ Cardiovasc Interv (2014) 0.75